Letters to the Editor
Clarification Regarding Epidemiologic Concepts
Am Fam Physician. 2012 May 1;85(9):847-852.
Original Article: Usefulness of Procalcitonin Measurement in Reducing Antibiotic Use and Identifying Serious Bacterial Illness [AFP Journal Club]
Issue Date: July 15, 2011
Available at: http://www.aafp.org/afp/2011/0715/p177.html
to the editor: I appreciated the thoughtful and critical analysis by the authors of the AFP Journal Club on the impact of procalcitonin measurement in treating children one to 36 months of age presenting with fever without a source. However, in the discussion of the impact of disease prevalence on a diagnostic test's performance characteristics, the authors may have confused two concepts in clinical epidemiology: sensitivity/specificity and predictive value.1
One author stated that the sensitivity and specificity of a test may change depending on the prevalence of disease in the population in which the test is used. Yet, according to the textbook Clinical Epidemiology: The Essentials, “…the sensitivity and specificity of a test are said to be independent of the prevalence of the diseased individuals in the sample in which the test is being evaluated.”2 In theory, the sensitivity and specificity of procalcitonin measurement are independent of the prevalence of the target disease.
The test characteristic concept that the author may have actually been alluding to is the test's predictive value. The prevalence of the target disease in a population would affect the predictive value; positive predictive value decreases as the prevalence of the target disease decreases, and negative predictive value decreases as the prevalence of the target disease increases.
Author disclosure: No relevant financial affiliations to disclose.
1. Manzano S, Bailey B, Girodias JB, Galetto-Lacour A, Cousineau J, Delvin E. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial. Am J Emerg Med. 2010;28(6):647–653.
2. Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology: The Essentials. 3rd ed. Philadelphia, Pa.: Williams & Wilkins Co.; 1996:54–59.
in reply: Dr. McDiarmid is entirely correct. This discussion should have referred to positive and negative predictive value rather than sensitivity and specificity. I apologize for the confusion.
editor's note: As Dr. McDiarmid points out, sensitivity and specificity are characteristics of the test itself, and generally do not vary with disease prevalence, although this is not a hard and fast rule.1 Positive and negative predictive values are inherently tied to disease prevalence. As most clinicians know, a positive test in a population with a very low disease prevalence is likely to be a false positive. Similarly, a negative test in a patient you think does have a certain disease has a good chance of being a false negative. Thus, positive and negative predictive values vary not only with disease prevalence, but, almost magically, with your clinical suspicion that a patient does or does not have the disease for which he or she is being tested.
For more information about the terms and concepts of clinical epidemiology, see our glossary of terms used in evidence-based medicine at http://www.aafp.org/journals/afp/authors/ebm-toolkit/glossary.html. This is one of several features in our Evidence-Based Medicine Toolkit available at http://www.aafp.org/afp/ebmtoolkit.
The online version of this AFP Journal Club discussion has been corrected to reflect the changes mentioned above.
1. Leeflang MM, Bossuyt PM, Irwig L. Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. J Clin Epidemiol. 2009;62(1):5–12.
Send letters to email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680. Include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the AAFP permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
This series is coordinated by Kenny Lin, MD, MPH, Associate Deputy Editor for AFP Online.
Copyright © 2012 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions